Profile
International Journal of Pediatrics & Neonatal Care Volume 1 (2015), Article ID 1:IJPNC-110, 4 pages
http://dx.doi.org/10.15344/2455-2364/2015/110
Research Article
Type 4 Retinol Binding Protein as a Marker of Hepatic Steatosis in Children and Adolescents with Type 2 Diabetes

Ana Carolina Hill de Tito1, Hanna Marrodán García1, Miguel Klünder Klünder2, María Teresa Valadez Reyes3, Fengyang Huang4, Mario Molina Díaz1, Lubia Velázquez López5 and Patricia Medina Bravo1*

1Department of Endocrinology, Hospital Infantil de México Federico Gómez, Mexico
2Department of Community Health Research, Hospital Infantil de México Federico Gómez, Mexico
3Department of Radiology, Hospital Infantil de México Federico Gómez, Mexico
4Department of Pharmacology, Hospital Infantil de México Federico Gómez, Mexico
5Clinical Epidemiology Research Unit, Hospital Regional General No. 1 Carlos McGregor Sánchez-Navarro, Instituto Mexicano del Seguro Social, Mexico
Dr. Patricia Medina Bravo, Endocrinology Department, Hospital Infantil de México Federico Gómez, Dr. Márquez No. 162, Colonia Doctores. Delegación Cuauhtémoc, C. P. 06720, Mexico, Tel: +5252289917; E-mail: drapatty_75@hotmail.com
24 March 2015; 20 November 2015; 24 November 2015
de Tito ACH, García HM, Klünder MK, Reyes MTV, Huang F, et al. (2015) Type 4 Retinol Binding Protein as a Marker of Hepatic Steatosis in Children and Adolescents with Type 2 Diabetes. Int J Pediatr Neonat Care 1: 110. doi: http://dx.doi.org/10.15344/2455-2364/2015/110

References

  1. Writing Group for the SEARCH for Diabetes in Youth Study Group1, Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, et al. (2007) Incidence of diabetes in youth in the United States. JAMA 297: 2716-2724 [CrossRef] [Google Scholar] [PubMed]
  2. Pinhas-Hamiel O, Zeitler P (2007) Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369: 1823-1831 [CrossRef] [Google Scholar] [PubMed]
  3. Clark JM, Diehl AM (2002) Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2: 210-215 [Google Scholar] [PubMed]
  4. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE (2009) Advances in pediatric nonalcoholic fatty liver disease. Hepatology 50: 1282-1293 [CrossRef] [Google Scholar] [PubMed]
  5. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123: 745-750 [CrossRef] [Google Scholar] [PubMed]
  6. Guiu B, Crevisy-Girod E, Binquet C, Duvillard L, Masson D, et al. (2012) Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy. Eur Radiol 22: 855-863 [CrossRef] [Google Scholar] [PubMed]
  7. Kotnik P, Fischer-Posovszky P, Wabitsch M (2011) RBP4: a controversial adipokine. Eur J Endocrinol 165: 703-711 [CrossRef] [Google Scholar] [PubMed]
  8. Esteve E, Ricart W, Fernández-Real JM (2009) Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 32 Suppl 2: S362-367 [CrossRef] [Google Scholar] [PubMed]
  9. Kelly KR, Kashyap SR, O'Leary VB, Major J, Schauer PR, (2010) Retinolbinding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity 18: 663-666 [CrossRef] [Google Scholar] [PubMed]
  10. Conroy R, Espinal Y, Fennoy I, Accacha S, Boucher-Berry C, et al. (2011) Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab 24: 913-919 [CrossRef] [Google Scholar] [PubMed]
  11. Huang SC, Yang YJ (2013) Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr Gastroenterol Nutr 56: 145-150 [CrossRef] [Google Scholar] [PubMed]
  12. Shaker O, El-Shehaby A, Zakaria A, Mostafa N, Talaat S, et al. (2011) Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Clin Biochem 44: 1457-1463 [CrossRef] [Google Scholar] [PubMed]
  13. Romanowska A, Lebensztejn DM, Skiba E, Tarasów E, Kaczmarski M (2011) Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children--preliminary report. Acta Biochim Pol 58: 35-38 [CrossRef] [Google Scholar] [PubMed]
  14. Angulo P, Keach JC, Batts KP, Lindor KD (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362 [CrossRef] [Google Scholar] [PubMed]
  15. American Diabetes Association (2012) Standards of medical care in diabetes--2012. Diabetes Care 35 Suppl 1: S11-63 [CrossRef] [Google Scholar] [PubMed]
  16. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, et al. (1996) Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119: 1533-1540 [CrossRef] [Google Scholar] [PubMed]
  17. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, et al. (1995) Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 40: 2002-2009 [CrossRef] [Google Scholar] [PubMed]
  18. Dean H, Sellers E (2001) Steatohepatitis in children with type 2 diabetes mellitus. Diabetes 2001 50: A378 [Google Scholar]
  19. Nadeau KJ, Klingensmith G, Zeitler P (2005) Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 41: 94-98 [CrossRef] [Google Scholar] [PubMed]